Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway
Acta Odontologica Scandinavica · 21.08.2025 · 84 · 479-490
DOI: 10.2340/aos.v84.44581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Odontologica Scandinavica, online erschienen am 21.08.2025. Verfasst von Lin Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Stomatology of Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Fibroblasts, TOR Serine-Threonine Kinases, Glycolysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inflammaging plays a pivotal role in the pathogenesis of multiple age-related diseases, including periodontitis. Advanced glycation end products (AGEs) are known to induce inflammaging and exacerbate periodontitis. However, the mechanisms by which AGEs promote inflammaging remain unclear. This study aimed to investigate the mechanisms underlying AGE-induced inflammaging. Methods and results: Human periodontal ligament fibroblasts (hPDLFs) were extracted and stimulated with lipopolysaccharide (LPS), with prior treatment using AGEs. The expression of pro-inflammatory cytokines was measured to explore the role of AGEs in LPS-induced inflammation. Subsequently, hPDLFs were treated with AGEs and pre-incubated with 2-deoxyglucose (2-DG, a glycolysis inhibitor), Ly294002 (an AKT/mTOR pathway inhibitor), and FPS-ZM1 (a receptor for advanced glycation end product [RAGE] antagonist) to assess the levels of inflammaging markers, glycolysis, AKT/mTOR pathway activation, and RAGE expression, along with the potential relationships among these factors. Our findings demonstrated that AGEs significantly increased the expression of pro-inflammatory cytokines in response to LPS stimulation. Additionally, AGEs alone elevated the levels of inflammaging factors, including cell senescence, senescence-associated secretory phenotype factors, SA-β-Gal expression, glycolysis markers, and AKT/mTOR pathway activation. Furthermore, inhibiting glycolysis reduced AGE-induced inflammaging, while blocking the AKT/mTOR pathway, suppressed both AGE-induced inflammaging and glycolysis. Antagonizing RAGE effectively blocked AGE-induced inflammaging, glycolysis, and AKT/mTOR pathway activation.
Conclusions
Our study indicated that AGE-induced inflammaging through binding to RAGE to activate the AKT/mTOR pathway and eventually enhancing glycolysis level, which may contribute to the increased inflammatory response triggered by LPS. These findings suggest that inflammaging is a critical mechanism through which AGEs exacerbate periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Stomatology of Guizhou Medical University, Guiyang, China.
- Department of Prosthodontics, Stomatological Hospital of Guizhou Medical University, Guiyang, China.
- Department of Prosthodontics, Stomatological Hospital of Guizhou Medical University, Guiyang, China. helinchen0509@163.com.
Zitieren
APA
Xiong, L., Shu, J., Gao, H., Qin, Y., Zhang, Y., Chang, X., Dong, Q., & Chen, H. (2025). Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway. Acta Odontologica Scandinavica, 84, 479-490. https://doi.org/10.2340/aos.v84.44581
Vancouver
Xiong L, Shu J, Gao H, Qin Y, Zhang Y, Chang X, et al. Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway. Acta Odontologica Scandinavica. 2025;84:479-490. doi:10.2340/aos.v84.44581
BibTeX
@article{Xiong2025,
author = {Xiong, Lin and Shu, Jiayu and Gao, Hongli and Qin, Yufeng and Zhang, Yuehan and Chang, Xuelian and Dong, Qiang and Chen, Helin},
title = {Advanced glycation end products induce inflammaging in periodontal ligament fibroblasts through RAGE/AKT/mTOR/glycolysis pathway},
journal = {Acta Odontologica Scandinavica},
year = {2025},
volume = {84},
pages = {479--490},
doi = {10.2340/aos.v84.44581}
}
EUVIMED